Bayer will present new data from two different studies of Adempas (riociguat) for pulmonary arterial hypertension (PAH) at the American…
Articles by Magdalena Kegel
Early treatment with Tracleer (bosentan) may delay the development of pulmonary arterial hypertension (PAH) in people with scleroderma, according to a study that compared…
Reata Pharmaceuticals has enrolled the first patient in its Phase 3 CATALYST trial (NCT02657356), exploring the potential benefits of bardoxolone…
A case report of pulmonary hypertension in a patient with heterotaxy syndrome — a condition where organs in the chest or…
Research into, and care of, patients with both congenital heart disease and pulmonary arterial hypertension (PAH) need to be optimized…
A molecule called PHD2 in the cells lining blood vessels in the lungs protects mice from the blood vessel remodeling…
Both patients newly diagnosed with pulmonary arterial hypertension (PAH) and animal models of the disease show increased activity of a molecular pathway, known…
Patients with pulmonary arterial hypertension (PAH) who fail to benefit from treatment with phosphodiesterase 5 inhibitors (PDE5i) may safely switch to…
A clinical trial exploring if Rituxan (rituximab) is effective in managing pulmonary arterial hypertension (PAH) in patients with scleroderma is…
Increased levels of the blood plasma protein endothelin-1 are linked to pulmonary hypertension in African-Americans, according to a large study exploring…
Further evidence that the oral drug Orenitram (treprostinil) might be a viable option to Remodulin, the injected version of the drug, for…
Patients with pulmonary hypertension (PH) have much higher levels of the blood vessel factor TSP-1 in their blood, with levels coinciding…